The Latest Breaking News on Pharma

Pfizer, which warned of a $5.5 billion writedown of its Covid treatment inventories earlier this month, posted a narrower-than-expected third quarter loss Tuesday.

Drugstore employees around the country have started calling in sick to highlight a lack of support from their employers

Letter from education department presses for schools to train students and faculty in how to administer medication

The Dove and Magnum maker says it wants to make a ‘positive impact’ but pays taxes to a state waging an illegal war in Ukraine

Amgen (AMGN) is scheduled to report its third-quarter earnings soon, with Wall Street analysts expecting year-over-year improvements in revenue. However, its earnings are expected to miss the consensus estimate. Moreover, the company completed the acquisition of Horizon Therapeutics earlier this month. Considering these factors, is the stock a buy or…

Community pharmacies across Scotland are being provided with a drug which can reverse overdoses.

The COVID-19 treatments millions of have taken for free from the federal government will enter the private market next week with a hefty price tag

The U.S. Customs and Border Protection has announced a new government-wide strategy that will target not only fentanyl but precursor materials used to make the synthetic opioid

Biogen stock tumbled Thursday — pulling Prothena stock down — on mixed test results for an updated version of its Alzheimer's treatment.

The pharmaceutical sector is expected to thrive due to the rising demand for advanced medicines to treat lifestyle diseases and its increasing ability to meet quality treatment needs thanks to technological advancements. Therefore, it could be wise to add fundamentally strong pharma stocks Amneal Pharmaceuticals (AMRX), Dr. Reddy’s Laboratories (RDY),…

This leading health stock is near all-time highs and in a base. Shares have outperformed the S&P 500 this year.